Valuation: ResMed, Inc.

Market Cap 3.22TCr 2.79TCr 2.62TCr 2.39TCr 4.52TCr 3,06700Cr 4.58TCr 31TCr 12TCr 1,53300Cr 12TCr 12TCr 5,10100Cr P/E 2026
18.7x
P/E 2027 * 19.7x
Enterprise Value 3.14TCr 2.72TCr 2.55TCr 2.33TCr 4.4TCr 2,98700Cr 4.46TCr 30TCr 12TCr 1,49200Cr 12TCr 12TCr 4,96700Cr EV / Sales 2026
4.98x
EV / Sales 2027 * 5.08x
Free-Float
75.61%
Yield 2026 *
1.09%
Yield 2027 * 1.17%
1 day-0.35%
1 week+7.04%
Current month+5.81%
1 month+2.22%
3 months+6.49%
6 months-17.81%
Current year-7.32%
1 week 210.93
Extreme 210.93
226.12
1 month 190.21
Extreme 190.21
226.12
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
09/02/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+7.04%-20.40%+24.54% 3.22TCr
+0.38%+0.56%+29.20%+5.72% 21TCr
+0.16%+1.94%+2.46%-21.50% 14TCr
-0.40%+5.88%-21.17%+20.82% 13TCr
+3.27%+7.17%-52.11%-2.80% 7.14TCr
+0.39%+2.76%+13.62%+12.28% 5.15TCr
+1.11%+6.89%-14.66%-19.25% 5.02TCr
+0.16%+1.90%+24.83%+11.91% 3.99TCr
-0.08%+5.10%+43.92%+37.88% 3.92TCr
+0.10%+0.53%+0.50%-7.36% 3.18TCr
Average +0.48%+3.90%+0.62%+6.22% 8.03TCr
Weighted average by Cap. +0.45%+3.30%+2.65%+3.66%

Financials

2026 2027 *
Net sales 565.08Cr 490.37Cr 459.18Cr 420.03Cr 792.96Cr 54TCr 803.31Cr 5.37TCr 2.11TCr 27TCr 2.12TCr 2.08TCr 90TCr 599.46Cr 520.21Cr 487.12Cr 445.59Cr 841.21Cr 57TCr 852.19Cr 5.7TCr 2.24TCr 29TCr 2.25TCr 2.2TCr 95TCr
Net income 154.63Cr 134.19Cr 125.65Cr 114.94Cr 216.99Cr 15TCr 219.82Cr 1.47TCr 576.9Cr 7.36TCr 580.58Cr 567.96Cr 24TCr 160.77Cr 139.51Cr 130.64Cr 119.5Cr 225.6Cr 15TCr 228.55Cr 1.53TCr 599.79Cr 7.65TCr 603.61Cr 590.49Cr 25TCr
Net Debt -84Cr -73Cr -69Cr -63Cr -118.51Cr -8.05TCr -120.06Cr -802.87Cr -315.09Cr -4.02TCr -317.1Cr -310.2Cr -13TCr -173.16Cr -150.27Cr -140.71Cr -128.71Cr -242.99Cr -16TCr -246.17Cr -1.65TCr -646.03Cr -8.24TCr -650.15Cr -636.02Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
06/26/06 $223.24 -0.35% 17,86,085
05/26/05 $224.03 +0.40% 17,46,578
04/26/04 $223.14 +3.69% 17,42,551
03/26/03 $215.19 +2.00% 14,66,073
31/26/31 $210.98 +1.16% 11,13,759
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
223.24USD
Average target price
248.53USD
Spread / Average Target
+11.33%

Quarterly revenue - Rate of surprise